These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9149701)

  • 1. Orally active prostacyclin analogue in primary pulmonary hypertension.
    Okano Y; Yoshioka T; Shimouchi A; Satoh T; Kunieda T
    Lancet; 1997 May; 349(9062):1365. PubMed ID: 9149701
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial hemodynamic effects of oral prostacyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension--a case report.
    Hashida H; Hamada M; Shigematsu Y; Ikeda S; Kuwahara T; Kawakami H; Hara Y; Kodama K; Kohara K; Hiwada K
    Angiology; 1998 Feb; 49(2):161-4. PubMed ID: 9482517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension.
    Ono F; Nagaya N; Kyotani S; Oya H; Nakanishi N; Miyatake K
    Circ J; 2003 May; 67(5):375-8. PubMed ID: 12736472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies for pulmonary hypertension: striving for efficacy and safety.
    Kao PN; Faul JL
    J Am Coll Cardiol; 2003 Jun; 41(12):2126-9. PubMed ID: 12821235
    [No Abstract]   [Full Text] [Related]  

  • 5. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
    Matthes J; Mathen F; Herzig S; Wassermann K
    Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension.
    Saji T; Ozawa Y; Ishikita T; Matsuura H; Matsuo N
    Am J Cardiol; 1996 Jul; 78(2):244-7. PubMed ID: 8712155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epoprostenol for primary pulmonary hypertension.
    Med Lett Drugs Ther; 1996 Feb; 38(968):14-5. PubMed ID: 8592477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of acute hemodynamic responses to prostacyclin with standard vasodilators in patients with primary pulmonary hypertension.
    Palevsky HI; Fishman AP
    Chest; 1988 Mar; 93(3 Suppl):179S. PubMed ID: 3277819
    [No Abstract]   [Full Text] [Related]  

  • 10. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary pulmonary hypertension. Treatment with prostacyclin I2 (epoprostenol)].
    Vicente R; Ramos F; Morales P
    Rev Esp Anestesiol Reanim; 1999; 46(6):274. PubMed ID: 10439652
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
    Gomberg-Maitland M; Preston IR
    Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostacyclin derivatives].
    Nagaya N
    Nihon Rinsho; 2008 Nov; 66(11):2145-50. PubMed ID: 19051734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in prostacyclin therapy for pulmonary arterial hypertension.
    Eells PL
    Crit Care Nurse; 2004 Apr; 24(2):42-8, 50-4. PubMed ID: 15098310
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of infantile primary pulmonary hypertension by intravenous infusion of lipo-prostaglandin I2 analog.
    Takigiku K; Shibata T; Yasui K; Iwamoto M; Sagawa K; Yamaoka K; Tsuda N
    J Pediatr; 1997 May; 130(5):835-8. PubMed ID: 9152299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction.
    Wang A; Bashore TM
    Eur Heart J; 1997 Sep; 18(9):1364-5. PubMed ID: 9458437
    [No Abstract]   [Full Text] [Related]  

  • 18. First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance.
    Sablotzki A; Czeslick E; Gruenig E; Friedrich I; Schubert S; Börgermann J; Hentschel T
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):960-2. PubMed ID: 12698166
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.
    Nagaya N; Uematsu M; Okano Y; Satoh T; Kyotani S; Sakamaki F; Nakanishi N; Miyatake K; Kunieda T
    J Am Coll Cardiol; 1999 Oct; 34(4):1188-92. PubMed ID: 10520811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arterial hypertension in a Kartagener syndrome patient: treatment with beraprost sodium.
    Shen YC; Wen FQ; Yi Q
    Int J Cardiol; 2012 Aug; 159(1):e9-10. PubMed ID: 22104985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.